hs-InvestmentinLocalStartups-SGross.jpg
TypeZero develops software-based solutions so that individuals with Type 1 and Type 2 diabetes can manage their blood glucose levels.
Appears In
Seed fund chooses companies using research and technology developed by U.Va. professors
By Anugya Mittal | February 1, 2018The U.Va. LVG Seed Fund’s current portfolio consists of three companies —TypeZero Technologies, TearSolutions and Mission Secure.
